nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—CYP3A7—Ifosfamide—testicular cancer	0.092	0.128	CbGbCtD
Itraconazole—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.092	0.128	CbGbCtD
Itraconazole—CYP2B6—Ifosfamide—testicular cancer	0.0876	0.122	CbGbCtD
Itraconazole—CYP3A5—Ifosfamide—testicular cancer	0.069	0.0958	CbGbCtD
Itraconazole—CYP2B6—Cisplatin—testicular cancer	0.0426	0.0592	CbGbCtD
Itraconazole—CYP2E1—Etoposide—testicular cancer	0.0424	0.0589	CbGbCtD
Itraconazole—ABCB1—Dactinomycin—testicular cancer	0.038	0.0528	CbGbCtD
Itraconazole—CYP3A5—Etoposide—testicular cancer	0.033	0.0458	CbGbCtD
Itraconazole—CYP2B6—Doxorubicin—testicular cancer	0.0286	0.0396	CbGbCtD
Itraconazole—CYP3A4—Ifosfamide—testicular cancer	0.0269	0.0374	CbGbCtD
Itraconazole—ABCB1—Vinblastine—testicular cancer	0.0238	0.0331	CbGbCtD
Itraconazole—CYP2D6—Vinblastine—testicular cancer	0.0225	0.0312	CbGbCtD
Itraconazole—ABCB1—Cisplatin—testicular cancer	0.0218	0.0303	CbGbCtD
Itraconazole—ABCB1—Etoposide—testicular cancer	0.0215	0.0298	CbGbCtD
Itraconazole—ABCB1—Doxorubicin—testicular cancer	0.0146	0.0203	CbGbCtD
Itraconazole—CYP3A4—Vinblastine—testicular cancer	0.0143	0.0198	CbGbCtD
Itraconazole—ABCB1—Methotrexate—testicular cancer	0.0142	0.0197	CbGbCtD
Itraconazole—CYP2D6—Doxorubicin—testicular cancer	0.0138	0.0192	CbGbCtD
Itraconazole—CYP3A4—Etoposide—testicular cancer	0.0129	0.0179	CbGbCtD
Itraconazole—CYP3A4—Doxorubicin—testicular cancer	0.00877	0.0122	CbGbCtD
Itraconazole—Gastrointestinal pain—Etoposide—testicular cancer	0.000184	0.000658	CcSEcCtD
Itraconazole—Infestation—Doxorubicin—testicular cancer	0.000183	0.000654	CcSEcCtD
Itraconazole—Infestation NOS—Doxorubicin—testicular cancer	0.000183	0.000654	CcSEcCtD
Itraconazole—Drowsiness—Doxorubicin—testicular cancer	0.000183	0.000654	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—testicular cancer	0.000183	0.000653	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000181	0.000648	CcSEcCtD
Itraconazole—Vomiting—Ifosfamide—testicular cancer	0.000181	0.000647	CcSEcCtD
Itraconazole—Hypersensitivity—Cisplatin—testicular cancer	0.000181	0.000647	CcSEcCtD
Itraconazole—Renal failure—Doxorubicin—testicular cancer	0.00018	0.000643	CcSEcCtD
Itraconazole—Rash—Ifosfamide—testicular cancer	0.00018	0.000642	CcSEcCtD
Itraconazole—Dermatitis—Ifosfamide—testicular cancer	0.000179	0.000642	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—testicular cancer	0.000179	0.000641	CcSEcCtD
Itraconazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000179	0.000641	CcSEcCtD
Itraconazole—Urticaria—Etoposide—testicular cancer	0.000179	0.000639	CcSEcCtD
Itraconazole—Jaundice—Doxorubicin—testicular cancer	0.000178	0.000638	CcSEcCtD
Itraconazole—Rhinitis—Epirubicin—testicular cancer	0.000178	0.000636	CcSEcCtD
Itraconazole—Abdominal pain—Etoposide—testicular cancer	0.000178	0.000636	CcSEcCtD
Itraconazole—Body temperature increased—Etoposide—testicular cancer	0.000178	0.000636	CcSEcCtD
Itraconazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000178	0.000636	CcSEcCtD
Itraconazole—Hepatitis—Epirubicin—testicular cancer	0.000178	0.000635	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—testicular cancer	0.000177	0.000634	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—testicular cancer	0.000177	0.000632	CcSEcCtD
Itraconazole—Hypoaesthesia—Epirubicin—testicular cancer	0.000177	0.000631	CcSEcCtD
Itraconazole—Asthenia—Cisplatin—testicular cancer	0.000176	0.00063	CcSEcCtD
Itraconazole—Pharyngitis—Epirubicin—testicular cancer	0.000176	0.00063	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—testicular cancer	0.000176	0.000629	CcSEcCtD
Itraconazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000175	0.000627	CcSEcCtD
Itraconazole—Oedema peripheral—Epirubicin—testicular cancer	0.000175	0.000625	CcSEcCtD
Itraconazole—Haematuria—Doxorubicin—testicular cancer	0.000174	0.000624	CcSEcCtD
Itraconazole—Connective tissue disorder—Epirubicin—testicular cancer	0.000174	0.000624	CcSEcCtD
Itraconazole—Urethral disorder—Epirubicin—testicular cancer	0.000174	0.000622	CcSEcCtD
Itraconazole—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000173	0.000619	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—testicular cancer	0.000172	0.000615	CcSEcCtD
Itraconazole—Sinusitis—Doxorubicin—testicular cancer	0.000172	0.000614	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—testicular cancer	0.000171	0.000613	CcSEcCtD
Itraconazole—Visual impairment—Epirubicin—testicular cancer	0.000171	0.000612	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—testicular cancer	0.000171	0.000611	CcSEcCtD
Itraconazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000171	0.00061	CcSEcCtD
Itraconazole—Chills—Methotrexate—testicular cancer	0.00017	0.000608	CcSEcCtD
Itraconazole—Nausea—Ifosfamide—testicular cancer	0.000169	0.000605	CcSEcCtD
Itraconazole—Diarrhoea—Cisplatin—testicular cancer	0.000168	0.000601	CcSEcCtD
Itraconazole—Erythema multiforme—Epirubicin—testicular cancer	0.000168	0.0006	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—testicular cancer	0.000168	0.000599	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—testicular cancer	0.000166	0.000594	CcSEcCtD
Itraconazole—Eye disorder—Epirubicin—testicular cancer	0.000166	0.000593	CcSEcCtD
Itraconazole—Hypersensitivity—Etoposide—testicular cancer	0.000166	0.000593	CcSEcCtD
Itraconazole—Tinnitus—Epirubicin—testicular cancer	0.000166	0.000592	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—testicular cancer	0.000165	0.00059	CcSEcCtD
Itraconazole—Cardiac disorder—Epirubicin—testicular cancer	0.000165	0.000589	CcSEcCtD
Itraconazole—Rhinitis—Doxorubicin—testicular cancer	0.000165	0.000589	CcSEcCtD
Itraconazole—Hepatitis—Doxorubicin—testicular cancer	0.000164	0.000587	CcSEcCtD
Itraconazole—Hypoaesthesia—Doxorubicin—testicular cancer	0.000163	0.000584	CcSEcCtD
Itraconazole—Pharyngitis—Doxorubicin—testicular cancer	0.000163	0.000583	CcSEcCtD
Itraconazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000162	0.00058	CcSEcCtD
Itraconazole—Oedema peripheral—Doxorubicin—testicular cancer	0.000162	0.000578	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—testicular cancer	0.000162	0.000578	CcSEcCtD
Itraconazole—Asthenia—Etoposide—testicular cancer	0.000161	0.000577	CcSEcCtD
Itraconazole—Connective tissue disorder—Doxorubicin—testicular cancer	0.000161	0.000577	CcSEcCtD
Itraconazole—Angiopathy—Epirubicin—testicular cancer	0.000161	0.000576	CcSEcCtD
Itraconazole—Urethral disorder—Doxorubicin—testicular cancer	0.000161	0.000576	CcSEcCtD
Itraconazole—Immune system disorder—Epirubicin—testicular cancer	0.00016	0.000573	CcSEcCtD
Itraconazole—Mediastinal disorder—Epirubicin—testicular cancer	0.00016	0.000572	CcSEcCtD
Itraconazole—Back pain—Methotrexate—testicular cancer	0.00016	0.000571	CcSEcCtD
Itraconazole—Chills—Epirubicin—testicular cancer	0.000159	0.000569	CcSEcCtD
Itraconazole—Pruritus—Etoposide—testicular cancer	0.000159	0.000569	CcSEcCtD
Itraconazole—Arrhythmia—Epirubicin—testicular cancer	0.000159	0.000567	CcSEcCtD
Itraconazole—Visual impairment—Doxorubicin—testicular cancer	0.000158	0.000566	CcSEcCtD
Itraconazole—Alopecia—Epirubicin—testicular cancer	0.000157	0.000561	CcSEcCtD
Itraconazole—Vomiting—Cisplatin—testicular cancer	0.000156	0.000558	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—testicular cancer	0.000156	0.000556	CcSEcCtD
Itraconazole—Mental disorder—Epirubicin—testicular cancer	0.000156	0.000556	CcSEcCtD
Itraconazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000155	0.000555	CcSEcCtD
Itraconazole—Rash—Cisplatin—testicular cancer	0.000155	0.000554	CcSEcCtD
Itraconazole—Dermatitis—Cisplatin—testicular cancer	0.000155	0.000553	CcSEcCtD
Itraconazole—Malnutrition—Epirubicin—testicular cancer	0.000155	0.000552	CcSEcCtD
Itraconazole—Diarrhoea—Etoposide—testicular cancer	0.000154	0.00055	CcSEcCtD
Itraconazole—Eye disorder—Doxorubicin—testicular cancer	0.000154	0.000549	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—testicular cancer	0.000153	0.000548	CcSEcCtD
Itraconazole—Tinnitus—Doxorubicin—testicular cancer	0.000153	0.000547	CcSEcCtD
Itraconazole—Cardiac disorder—Doxorubicin—testicular cancer	0.000152	0.000545	CcSEcCtD
Itraconazole—Flatulence—Epirubicin—testicular cancer	0.000152	0.000544	CcSEcCtD
Itraconazole—Dysgeusia—Epirubicin—testicular cancer	0.000151	0.000541	CcSEcCtD
Itraconazole—Back pain—Epirubicin—testicular cancer	0.000149	0.000534	CcSEcCtD
Itraconazole—Angiopathy—Doxorubicin—testicular cancer	0.000149	0.000533	CcSEcCtD
Itraconazole—Malaise—Methotrexate—testicular cancer	0.000149	0.000532	CcSEcCtD
Itraconazole—Dizziness—Etoposide—testicular cancer	0.000149	0.000532	CcSEcCtD
Itraconazole—Immune system disorder—Doxorubicin—testicular cancer	0.000148	0.00053	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—testicular cancer	0.000148	0.00053	CcSEcCtD
Itraconazole—Mediastinal disorder—Doxorubicin—testicular cancer	0.000148	0.000529	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—testicular cancer	0.000148	0.000528	CcSEcCtD
Itraconazole—Chills—Doxorubicin—testicular cancer	0.000147	0.000527	CcSEcCtD
Itraconazole—Arrhythmia—Doxorubicin—testicular cancer	0.000147	0.000525	CcSEcCtD
Itraconazole—Nausea—Cisplatin—testicular cancer	0.000146	0.000521	CcSEcCtD
Itraconazole—Vision blurred—Epirubicin—testicular cancer	0.000146	0.000521	CcSEcCtD
Itraconazole—Alopecia—Doxorubicin—testicular cancer	0.000145	0.000519	CcSEcCtD
Itraconazole—Cough—Methotrexate—testicular cancer	0.000144	0.000515	CcSEcCtD
Itraconazole—Mental disorder—Doxorubicin—testicular cancer	0.000144	0.000514	CcSEcCtD
Itraconazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000143	0.000513	CcSEcCtD
Itraconazole—Vomiting—Etoposide—testicular cancer	0.000143	0.000511	CcSEcCtD
Itraconazole—Malnutrition—Doxorubicin—testicular cancer	0.000143	0.000511	CcSEcCtD
Itraconazole—Rash—Etoposide—testicular cancer	0.000142	0.000507	CcSEcCtD
Itraconazole—Dermatitis—Etoposide—testicular cancer	0.000142	0.000507	CcSEcCtD
Itraconazole—Headache—Etoposide—testicular cancer	0.000141	0.000504	CcSEcCtD
Itraconazole—Flatulence—Doxorubicin—testicular cancer	0.000141	0.000504	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—testicular cancer	0.000141	0.000503	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—testicular cancer	0.000141	0.000503	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—testicular cancer	0.000141	0.000503	CcSEcCtD
Itraconazole—Dysgeusia—Doxorubicin—testicular cancer	0.00014	0.000501	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00014	0.000499	CcSEcCtD
Itraconazole—Malaise—Epirubicin—testicular cancer	0.000139	0.000498	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—testicular cancer	0.000139	0.000497	CcSEcCtD
Itraconazole—Vertigo—Epirubicin—testicular cancer	0.000139	0.000496	CcSEcCtD
Itraconazole—Syncope—Epirubicin—testicular cancer	0.000139	0.000495	CcSEcCtD
Itraconazole—Leukopenia—Epirubicin—testicular cancer	0.000138	0.000494	CcSEcCtD
Itraconazole—Back pain—Doxorubicin—testicular cancer	0.000138	0.000494	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—testicular cancer	0.000136	0.000486	CcSEcCtD
Itraconazole—Loss of consciousness—Epirubicin—testicular cancer	0.000136	0.000486	CcSEcCtD
Itraconazole—Cough—Epirubicin—testicular cancer	0.000135	0.000482	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—testicular cancer	0.000135	0.000482	CcSEcCtD
Itraconazole—Vision blurred—Doxorubicin—testicular cancer	0.000135	0.000482	CcSEcCtD
Itraconazole—Infection—Methotrexate—testicular cancer	0.000134	0.000479	CcSEcCtD
Itraconazole—Nausea—Etoposide—testicular cancer	0.000134	0.000478	CcSEcCtD
Itraconazole—Hypertension—Epirubicin—testicular cancer	0.000133	0.000477	CcSEcCtD
Itraconazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000133	0.000474	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—testicular cancer	0.000132	0.000472	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000132	0.000472	CcSEcCtD
Itraconazole—Arthralgia—Epirubicin—testicular cancer	0.000132	0.00047	CcSEcCtD
Itraconazole—Chest pain—Epirubicin—testicular cancer	0.000132	0.00047	CcSEcCtD
Itraconazole—Myalgia—Epirubicin—testicular cancer	0.000132	0.00047	CcSEcCtD
Itraconazole—Anxiety—Epirubicin—testicular cancer	0.000131	0.000469	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—testicular cancer	0.000131	0.000468	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000131	0.000467	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—testicular cancer	0.00013	0.000466	CcSEcCtD
Itraconazole—Discomfort—Epirubicin—testicular cancer	0.00013	0.000465	CcSEcCtD
Itraconazole—Malaise—Doxorubicin—testicular cancer	0.000129	0.000461	CcSEcCtD
Itraconazole—Vertigo—Doxorubicin—testicular cancer	0.000128	0.000459	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—testicular cancer	0.000128	0.000459	CcSEcCtD
Itraconazole—Syncope—Doxorubicin—testicular cancer	0.000128	0.000458	CcSEcCtD
Itraconazole—Leukopenia—Doxorubicin—testicular cancer	0.000128	0.000458	CcSEcCtD
Itraconazole—Confusional state—Epirubicin—testicular cancer	0.000127	0.000455	CcSEcCtD
Itraconazole—Anaphylactic shock—Epirubicin—testicular cancer	0.000126	0.000451	CcSEcCtD
Itraconazole—Oedema—Epirubicin—testicular cancer	0.000126	0.000451	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—testicular cancer	0.000126	0.00045	CcSEcCtD
Itraconazole—Loss of consciousness—Doxorubicin—testicular cancer	0.000126	0.000449	CcSEcCtD
Itraconazole—Infection—Epirubicin—testicular cancer	0.000125	0.000448	CcSEcCtD
Itraconazole—Cough—Doxorubicin—testicular cancer	0.000125	0.000446	CcSEcCtD
Itraconazole—Shock—Epirubicin—testicular cancer	0.000124	0.000444	CcSEcCtD
Itraconazole—Nervous system disorder—Epirubicin—testicular cancer	0.000124	0.000442	CcSEcCtD
Itraconazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000123	0.000441	CcSEcCtD
Itraconazole—Hypertension—Doxorubicin—testicular cancer	0.000123	0.000441	CcSEcCtD
Itraconazole—Tachycardia—Epirubicin—testicular cancer	0.000123	0.00044	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000123	0.000439	CcSEcCtD
Itraconazole—Skin disorder—Epirubicin—testicular cancer	0.000123	0.000438	CcSEcCtD
Itraconazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000122	0.000436	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—testicular cancer	0.000122	0.000436	CcSEcCtD
Itraconazole—Chest pain—Doxorubicin—testicular cancer	0.000122	0.000435	CcSEcCtD
Itraconazole—Arthralgia—Doxorubicin—testicular cancer	0.000122	0.000435	CcSEcCtD
Itraconazole—Myalgia—Doxorubicin—testicular cancer	0.000122	0.000435	CcSEcCtD
Itraconazole—Anxiety—Doxorubicin—testicular cancer	0.000121	0.000434	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—testicular cancer	0.000121	0.000433	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000121	0.000432	CcSEcCtD
Itraconazole—Discomfort—Doxorubicin—testicular cancer	0.00012	0.00043	CcSEcCtD
Itraconazole—Anorexia—Epirubicin—testicular cancer	0.00012	0.00043	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—testicular cancer	0.00012	0.00043	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—testicular cancer	0.00012	0.000428	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—testicular cancer	0.000119	0.000424	CcSEcCtD
Itraconazole—Hypotension—Epirubicin—testicular cancer	0.000118	0.000421	CcSEcCtD
Itraconazole—Confusional state—Doxorubicin—testicular cancer	0.000118	0.000421	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—testicular cancer	0.000117	0.000419	CcSEcCtD
Itraconazole—Anaphylactic shock—Doxorubicin—testicular cancer	0.000117	0.000417	CcSEcCtD
Itraconazole—Oedema—Doxorubicin—testicular cancer	0.000117	0.000417	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000116	0.000416	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—testicular cancer	0.000116	0.000415	CcSEcCtD
Itraconazole—Infection—Doxorubicin—testicular cancer	0.000116	0.000414	CcSEcCtD
Itraconazole—Pain—Methotrexate—testicular cancer	0.000115	0.000412	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000115	0.000411	CcSEcCtD
Itraconazole—Shock—Doxorubicin—testicular cancer	0.000115	0.00041	CcSEcCtD
Itraconazole—Nervous system disorder—Doxorubicin—testicular cancer	0.000114	0.000409	CcSEcCtD
Itraconazole—Thrombocytopenia—Doxorubicin—testicular cancer	0.000114	0.000408	CcSEcCtD
Itraconazole—Insomnia—Epirubicin—testicular cancer	0.000114	0.000408	CcSEcCtD
Itraconazole—Tachycardia—Doxorubicin—testicular cancer	0.000114	0.000407	CcSEcCtD
Itraconazole—Skin disorder—Doxorubicin—testicular cancer	0.000113	0.000405	CcSEcCtD
Itraconazole—Paraesthesia—Epirubicin—testicular cancer	0.000113	0.000405	CcSEcCtD
Itraconazole—Hyperhidrosis—Doxorubicin—testicular cancer	0.000113	0.000403	CcSEcCtD
Itraconazole—Dyspnoea—Epirubicin—testicular cancer	0.000112	0.000402	CcSEcCtD
Itraconazole—Somnolence—Epirubicin—testicular cancer	0.000112	0.000401	CcSEcCtD
Itraconazole—Anorexia—Doxorubicin—testicular cancer	0.000111	0.000398	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—testicular cancer	0.000111	0.000397	CcSEcCtD
Itraconazole—Dyspepsia—Epirubicin—testicular cancer	0.000111	0.000397	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—testicular cancer	0.00011	0.000394	CcSEcCtD
Itraconazole—Decreased appetite—Epirubicin—testicular cancer	0.00011	0.000392	CcSEcCtD
Itraconazole—Hypotension—Doxorubicin—testicular cancer	0.000109	0.00039	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000109	0.000389	CcSEcCtD
Itraconazole—Fatigue—Epirubicin—testicular cancer	0.000109	0.000389	CcSEcCtD
Itraconazole—Pain—Epirubicin—testicular cancer	0.000108	0.000386	CcSEcCtD
Itraconazole—Constipation—Epirubicin—testicular cancer	0.000108	0.000386	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—testicular cancer	0.000107	0.000383	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—testicular cancer	0.000107	0.000381	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—testicular cancer	0.000107	0.000381	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000106	0.00038	CcSEcCtD
Itraconazole—Insomnia—Doxorubicin—testicular cancer	0.000106	0.000377	CcSEcCtD
Itraconazole—Paraesthesia—Doxorubicin—testicular cancer	0.000105	0.000375	CcSEcCtD
Itraconazole—Dyspnoea—Doxorubicin—testicular cancer	0.000104	0.000372	CcSEcCtD
Itraconazole—Feeling abnormal—Epirubicin—testicular cancer	0.000104	0.000372	CcSEcCtD
Itraconazole—Somnolence—Doxorubicin—testicular cancer	0.000104	0.000371	CcSEcCtD
Itraconazole—Gastrointestinal pain—Epirubicin—testicular cancer	0.000103	0.000369	CcSEcCtD
Itraconazole—Dyspepsia—Doxorubicin—testicular cancer	0.000103	0.000367	CcSEcCtD
Itraconazole—Decreased appetite—Doxorubicin—testicular cancer	0.000101	0.000363	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000101	0.00036	CcSEcCtD
Itraconazole—Fatigue—Doxorubicin—testicular cancer	0.000101	0.00036	CcSEcCtD
Itraconazole—Urticaria—Epirubicin—testicular cancer	0.0001	0.000358	CcSEcCtD
Itraconazole—Pain—Doxorubicin—testicular cancer	9.98e-05	0.000357	CcSEcCtD
Itraconazole—Constipation—Doxorubicin—testicular cancer	9.98e-05	0.000357	CcSEcCtD
Itraconazole—Abdominal pain—Epirubicin—testicular cancer	9.97e-05	0.000356	CcSEcCtD
Itraconazole—Body temperature increased—Epirubicin—testicular cancer	9.97e-05	0.000356	CcSEcCtD
Itraconazole—Hypersensitivity—Methotrexate—testicular cancer	9.93e-05	0.000355	CcSEcCtD
Itraconazole—Asthenia—Methotrexate—testicular cancer	9.67e-05	0.000346	CcSEcCtD
Itraconazole—Feeling abnormal—Doxorubicin—testicular cancer	9.62e-05	0.000344	CcSEcCtD
Itraconazole—Gastrointestinal pain—Doxorubicin—testicular cancer	9.54e-05	0.000341	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—testicular cancer	9.54e-05	0.000341	CcSEcCtD
Itraconazole—Hypersensitivity—Epirubicin—testicular cancer	9.29e-05	0.000332	CcSEcCtD
Itraconazole—Urticaria—Doxorubicin—testicular cancer	9.27e-05	0.000331	CcSEcCtD
Itraconazole—Abdominal pain—Doxorubicin—testicular cancer	9.23e-05	0.00033	CcSEcCtD
Itraconazole—Body temperature increased—Doxorubicin—testicular cancer	9.23e-05	0.00033	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—testicular cancer	9.22e-05	0.00033	CcSEcCtD
Itraconazole—Asthenia—Epirubicin—testicular cancer	9.05e-05	0.000323	CcSEcCtD
Itraconazole—Pruritus—Epirubicin—testicular cancer	8.92e-05	0.000319	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—testicular cancer	8.91e-05	0.000319	CcSEcCtD
Itraconazole—Diarrhoea—Epirubicin—testicular cancer	8.63e-05	0.000308	CcSEcCtD
Itraconazole—Hypersensitivity—Doxorubicin—testicular cancer	8.6e-05	0.000307	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—testicular cancer	8.57e-05	0.000306	CcSEcCtD
Itraconazole—Rash—Methotrexate—testicular cancer	8.5e-05	0.000304	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—testicular cancer	8.49e-05	0.000303	CcSEcCtD
Itraconazole—Headache—Methotrexate—testicular cancer	8.44e-05	0.000302	CcSEcCtD
Itraconazole—Asthenia—Doxorubicin—testicular cancer	8.37e-05	0.000299	CcSEcCtD
Itraconazole—Dizziness—Epirubicin—testicular cancer	8.34e-05	0.000298	CcSEcCtD
Itraconazole—Pruritus—Doxorubicin—testicular cancer	8.26e-05	0.000295	CcSEcCtD
Itraconazole—Vomiting—Epirubicin—testicular cancer	8.02e-05	0.000287	CcSEcCtD
Itraconazole—Nausea—Methotrexate—testicular cancer	8.01e-05	0.000286	CcSEcCtD
Itraconazole—Diarrhoea—Doxorubicin—testicular cancer	7.98e-05	0.000285	CcSEcCtD
Itraconazole—Rash—Epirubicin—testicular cancer	7.95e-05	0.000284	CcSEcCtD
Itraconazole—Dermatitis—Epirubicin—testicular cancer	7.94e-05	0.000284	CcSEcCtD
Itraconazole—Headache—Epirubicin—testicular cancer	7.9e-05	0.000282	CcSEcCtD
Itraconazole—Dizziness—Doxorubicin—testicular cancer	7.72e-05	0.000276	CcSEcCtD
Itraconazole—Nausea—Epirubicin—testicular cancer	7.49e-05	0.000268	CcSEcCtD
Itraconazole—Vomiting—Doxorubicin—testicular cancer	7.42e-05	0.000265	CcSEcCtD
Itraconazole—Rash—Doxorubicin—testicular cancer	7.36e-05	0.000263	CcSEcCtD
Itraconazole—Dermatitis—Doxorubicin—testicular cancer	7.35e-05	0.000263	CcSEcCtD
Itraconazole—Headache—Doxorubicin—testicular cancer	7.31e-05	0.000261	CcSEcCtD
Itraconazole—Nausea—Doxorubicin—testicular cancer	6.93e-05	0.000248	CcSEcCtD
